Topeka's Cotton O'Neil is using a new, early diagnosis tool to test new Alzheimer's treatments.

During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being ...

The University of Houston convened leading scholars and researchers from across Texas for the inaugural Dementia Unlocked ...

Highlights from CTAD 2025 include GLP-1 agonist data, p-tau217 biomarker utility, subcutaneous lecanemab trials, and racial disparities in trial enrollment.

Researchers at Emory University have identified effective, community-driven strategies to increase participation by ...

Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy ...

Chronic traumatic encephalopathy has long been discussed as a possible driver of dementia, but proving that link has been ...

From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug. In 2023, the drug ...

A once-a-day pill that helps slow down the course of Alzheimer’s disease is a step closer to becoming a reality in a major ...

THC plus a common anti-inflammatory drug show promise.